Telprox 25

Telprox 25 Tablets combine Telmisartan and Metoprolol Succinate (Extended Release) in a single formulation to provide effective management of high blood pressure and associated cardiovascular risks. Telmisartan, an angiotensin II receptor blocker (ARB), works by relaxing blood vessels and preventing them from narrowing, thereby improving blood flow and reducing blood pressure. Metoprolol Succinate, a beta-blocker with extended release action, helps reduce the heart rate, workload, and strain on the heart, offering sustained 24-hour control of hypertension.

This combination therapy is particularly beneficial for patients requiring dual-action control for hypertension, especially those at risk of heart disease, stroke, or other cardiovascular complications. Telprox 25 not only aids in lowering elevated blood pressure but also helps in preventing long-term damage to the heart, kidneys, and blood vessels. Its extended-release formulation ensures consistent and steady drug levels in the body, enhancing patient compliance and convenience with once-daily dosing.

Telprox 25 Tablets are indicated for the treatment of essential hypertension and may be prescribed as part of a comprehensive cardiovascular risk management plan. With a 10 x 10 tablet pack, it offers an effective, reliable, and well-tolerated solution for long-term blood pressure control. This medication should be taken only under the guidance of a qualified healthcare professional.